http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 09 Jun 2026 09:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/Press+Releases/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html <div class="xn-content"> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1808"><p><img src="https://mmx.prnewswire.com/media/MS1414612/Perimeter_Medical_Imaging_AI_Inc.-Perimeter_Selected_for_INOVAIT.jpg?id=OA2692445" title="Perimeter Medical Imaging AI logo" alt="Perimeter Medical Imaging AI logo" /></p></div><p class="prntac"><i>Canadian government-backed contribution supports next-generation AI <br />development for Claire™, Perimeter's flagship intraoperative imaging platform</i></p><p><span class="legendSpanClass"><location value="LU/ca.on.tornto" idsrc="xmltag.org" >TORONTO</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ - <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=4179857594&amp;u=http%3A%2F%2Fwww.perimetermed.com%2F&amp;a=Perimeter+Medical+Imaging+AI%2C+Inc." target="_blank" rel="nofollow"><span value="TorontoVE:PINK" idsrc="xmltag.org" >Perimeter Medical Imaging AI, Inc.</span></a> (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") today announced it has been selected to receive a contribution from the <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4706933-1&amp;h=3604604762&amp;u=https%3A%2F%2Finovait.ca%2Ffunding%2F&amp;a=INOVAIT+Pilot+Fund" target="_blank" rel="nofollow"><span>INOVAIT Pilot Fund</span></a> to advance next-generation AI capabilities for its flagship product Claire™, which received <span value="ACORN:0682203466" idsrc="xmltag.org" >U.S. Food and Drug Administration</span> approval http://www.streetinsider.com/PRNewswire/Perimeter+Selected+for+INOVAIT+Pilot+Fund+to+Advance+AI+for+Breast+Cancer+Surgery/26621490.html Tue, 09 Jun 2026 09:05:00 -0400 A.06822034 A.07532317 A.26182308 A.60012013 O.02601292 O.03301479 O.20026344 O.40274385 O.54379156 PINK PYNKF PYNKF http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Perimeter+Medical+Imagin+++++++++++++/26594869.html si-local-file:///var/storage/secattach/20260603/26594869.html http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Perimeter+Medical+Imagin+++++++++++++/26594869.html Wed, 03 Jun 2026 06:05:00 -0400 O.02601292 PINK PYNKF